Micro/nanorobots have long been expected to reach all parts of the human body through blood vessels for medical treatment or surgery. However, in the current stage, it is still challenging to drive a microrobot in viscous media at high speed and difficult to observe the shape and position of a single microrobot once it enters the bloodstream. Here, we propose a new micro-rocket robot and an all-optic driving and imaging system that can actuate and track it in blood with microscale resolution. To achieve a high driving force, we engineer the microrobot to have a rocket-like tripletube structure. Owing to the interface design, the 3D-printed micro-rocket can reach a moving speed of 2.8 mm/s (62 body lengths per second) under near-infrared light actuation in a blood-mimicking viscous glycerol solution. We also show that the micro-rocket robot is successfully tracked at a 3.2-µm resolution with an optical-resolution photoacoustic microscope in blood. This work paves the way for microrobot design, actuation, and tracking in the blood environment, which may broaden the scope of microrobotic applications in the biomedical field.
Photoacoustic (PA) imaging and tracking
of stem cells plays an
important role in the real-time assessment of cell-based therapies.
Nevertheless, the limitations of conventional inorganic PA contrast
agents and the narrow range of the excitation wavelength in the first
near-infrared (NIR-I) window hamper the applications of PA imaging
in living subjects. Herein, we report the design and synthesis of
a second near-infrared (NIR-II) absorptive organic semiconducting
polymer (OSP)-based nanoprobe (OSPN+) for PA imaging and
tracking of stem cells. Comparison studies in biological tissue show
that NIR-II light excited PA imaging of the OSPN+ has significantly
higher signal-to-noise ratio than NIR-I light excited PA imaging,
thereby demonstrating the superiority of the OSPN+ for
deep tissue imaging. With good biocompatibility, appropriate size,
and optimized surface property, the OSPN+ shows enhanced
cellular uptake for highly efficient PA labeling of stem cells. In vivo investigations reveal significant NIR-II PA contrast
enhancement of the transplanted OSPN+-labeled human mesenchymal
stem cells by 40.6- and 21.7-fold in subcutaneous and brain imaging,
respectively, compared with unlabeled cases. Our work demonstrates
a class of OSP-based nanomaterials for NIR-II PA stem cell imaging
to facilitate a better understanding and evaluation of stem cell-based
therapies.
Precise
diagnosis and effective treatment of gliomas still remain
a huge challenge. Photoacoustic-guided photothermal therapy (PTT)
has unique advantages over conventional techniques for brain tumor
theranostics, but existing nanoagents for photoacoustic imaging (PAI)-guided
PTT are mainly organic small molecules or inorganic nanoparticles,
which have the limitations of poor photostability and biocompatibility.
Besides, the restricted absorption in the first near-infrared window
(NIR-I) of the most existing nanoagents compromises their effectiveness
for deep tissue PAI and PTT. We herein develop novel semiconducting
polymer nanoparticles (SPNs) that are strongly absorptive in the second
NIR window (NIR-II) to alleviate these problems. With the merits of
excellent photoacoustic and photothermal performance, high photostability,
proper size, and low toxicity, SPNs not only show efficient cellular
uptake for PAI and PTT toward U87 glioma cells but also demonstrate
effective accumulation in both subcutaneous tumors and brain tumors
upon intravenous injection, thereby realizing efficient PAI-guided
PTT toward gliomas under NIR-II light irradiation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.